Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03526432 |
| Title | Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Oklahoma |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UAB Women and Infants Center | Birmingham | Alabama | 35233 | United States | Details | |
| Washington University School of Medicine | Saint Louis | Missouri | 63108 | United States | Details | |
| Stephenson Cancer Center, University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73117 | United States | Details |